Aims The therapeutical management of atrial fibrillation (AF) in the setting of Brugada
syndrome (BS) might be challenging as many antiarrhythmic drugs (AADs) with sodium …

Aims Pharmacological treatment of atrial fibrillation (AF) in the setting of Brugada syndrome
(BS) might be challenging as many antiarrhythmic drugs (AADs) with sodium channel …

Background Pharmacological treatment of atrial fibrillation (AF) in the setting of Brugada
syndrome (BrS) is challenging. In addition, patients with BrS with an implantable …

Supraventricular arrhythmias are common in Brugada syndrome (BS), and notoriously
difficult to manage with medical therapy secondary to associated risks. Pulmonary vein …

Background In patients with an implantable cardioverter-defibrillator (ICD) and Brugada
syndrome (BrS), the long-term efficacy of catheter ablation for preventing inappropriate …

Background Medical therapy of atrial fibrillation (AF) can be challenging in patients with
Brugada electrocardiograms (ECGs). The purpose of this study was to investigate the …

Background Inappropriate shocks resulting from atrial tachyarrhythmias are highly
problematic for patients with an implantable cardioverter defibrillator (ICD). We aimed to …

Abstract Background Brugada Syndrome (BrS) is a life-threatening cardiac arrhythmia
disorder associated with an increased risk ventricular arrhythmias (VAs) and sudden cardiac …

The incidence of atrial fibrillation (AF) in Brugada syndrome (BrS) has been reported at
between 9% and 53% by different series, but the true prevalence is unknown. However, AF …

Aims This single-centre prospective study was designed to determine the incidence,
therapeutic implications and prognosis of atrial arrhythmias (AA) in patients with Brugada …